Detalhe da pesquisa
1.
Open-label phase 3 study of intravenous golimumab in patients with polyarticular juvenile idiopathic arthritis.
Rheumatology (Oxford)
; 60(10): 4495-4507, 2021 10 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33493312
2.
Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Results From a Phase III Open-Label Study.
Arthritis Rheumatol
; 70(7): 1144-1154, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29481737